✦ The News Desk
The full firehose — every desk, every dispatch, in chronological order. Last filed 10h ago.
No practice change warranted at this stage; this is a Phase 1/2 safety and dose-escalation trial — efficacy data are exploratory and insufficient to inform clinical decisions about treating speech-in-noise impairment.
✦ Search
✦ Filter
